Aura Biosciences Inc expected to post a loss of 49 cents a share - Earnings Preview

Aura Biosciences

29/07/2023 03:06

* Aura Biosciences Inc  AURA.OQ   AURA.O  is expected
to show no
change in quarterly revenue when it reports  results on August 1
(estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Aura Biosciences
Inc is
for a loss of 49 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aura
Biosciences
Inc is $30​, above​ its last closing price of $11.78. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.53       -0.54      -0.46     Beat    14.9
 Dec. 31 2023  -0.47       -0.52      -0.55     Missed  -5.3
 Sep. 30 2022  -0.51       -0.51      -0.54     Missed  -6.7​
 Jun. 30 2022  -0.46       -0.46      -0.46     Met     0.9
 ​​Mar.        -0.44       -0.44      -0.44     Met     -0.6
 31 2022                                                
 Dec. 31 2021  -0.39       -0.39      -2.51     Missed  -538.1
                                                        ​
 This summary was machine generated July 29 at 02:06 GMT.  All
figures in US dollars  unless otherwise stated